Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Verifiedinfo

Clinicly Sp. z o.o.

Poland Ul. Julianowska 54b, 91-473 Opole, Poland

  • 5 trials recruiting
  • Graves' disease · Obesity · Peripheral arterial occlusive disease
  • Adult patients

About Specializations

Clinicly Sp. z o.o. in Opole, Poland specialises in clinical trials of conditions such as Graves' disease, Obesity, Peripheral arterial occlusive disease, and other specialisations. This site conducts important research.

Main research areas of the site

Immune System Diseases

At Clinicly Sp. z o.o., researchers focus on Immune System Diseases, particularly Graves’ Disease. The trials aim to test a new therapeutic agent that restores normal thyroid hormone balance and reduces dependence on existing medication.

  • Evaluation of novel therapy for Graves’ Disease
  • Long‑term safety and durability of treatment
  • Assessment of hormone balance and medication reduction

The work is conducted at the Clinicly Sp. z o.o. Centrum Medyczne Clinicly in Opole, Poland.

Nutritional and Metabolic Diseases

The centre also investigates Nutritional and Metabolic Diseases, with emphasis on Obesity or Overweight without Type 2 Diabetes. Trials explore a potential weight‑management compound intended to achieve sustained body‑weight reduction.

  • Impact on body‑weight change over extended period
  • Safety profile in non‑diabetic participants
  • Effect on metabolic parameters and quality of life

These studies are part of the ongoing research program at Clinicly Sp. z o.o. in Opole.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Ul. Julianowska 54b91-473 OpolePoland
Open in maps ↗
Recruiting now
5 trials
Conditions studied
3
Partner status
Verified

More sites in OpolePoland

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

7 clinical trials

A Phase 3 Study of Orelabrutinib to Delay Disability Progression in Patients with Non‑Active Secondary Progressive Multiple Sclerosis

Recruiting
Investigational
Countries:PolandPoland
  • Participants:18–64 years
  • Sponsor:Zenas Biopharma (USA) LLC

Graves' disease

Recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Graves' disease

Recruiting
InvestigationalNo placebo
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:IMEROPRUBART
  • Sponsor:Immunovant Sciences GmbH

Peripheral arterial occlusive disease

Not yet recruiting
Registered drug
Countries:PolandPoland
  • Participants:18–64 years · 65+ years
  • Substances:Regn7508
  • Sponsor:Regeneron Pharmaceuticals Inc.
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.